1.         Stevens CAT, Vallejo-Vaz AJ, Chora JR, Barkas F, Brandts J, Mahani A, Abar L, Sharabiani MTA, Ray KK. Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution? J Am Heart Assoc 2024;13:e034434. doi: 10.1161/jaha.123.034434

2.         Barkas F, Sener YZ, Golforoush PA, Kheirkhah A, Rodriguez-Sanchez E, Novak J, Apellaniz-Ruiz M, Akyea RK, Bianconi V, Ceasovschih A, Chee YJ, Cherska M, Chora JR, D’Oria M, Demikhova N, Kocyigit Burunkaya D, Rimbert A, Macchi C, Rathod K, Roth L, Sukhorukov V, Stoica S, Scicali R, Storozhenko T, Uzokov J, Lupo MG, van der Vorst EPC, Porsch F. Advancements in risk stratification and management strategies in primary cardiovascular prevention. Atherosclerosis 2024;395:117579. doi: 10.1016/j.atherosclerosis.2024.117579

3.         Barkas F, Rizos CV, Liamis G, Skoumas I, Garoufi A, Rallidis L, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Kotsis V, Doumas M, Anagnostis P, Lambadiari V, Anastasiou G, Koutagiar I, Attilakos A, Kiouri E, Kolovou V, Polychronopoulos G, Koutsogianni AD, Zacharis E, Koumaras C, Antza C, Boutari C, Liberopoulos E. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry. J Clin Lipidol 2024;18:e394-e402. doi: 10.1016/j.jacl.2024.01.005

4.         Barkas F, Ray K. An update on inclisiran for the treatment of elevated LDL cholesterol. Expert Opin Pharmacother 2024;25:349-358. doi: 10.1080/14656566.2024.2337253

5.         Barkas F, Liberopoulos E, Rizzo M. Exploring the Landscape of Familial Hypercholesterolemia: Unraveling Genetic Complexity and Clinical Implications. Eur J Intern Med 2024;123:58-59. doi: 10.1016/j.ejim.2024.02.031

6.         Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Filippatos TD, Ray KK, Agouridis AP. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association? Atheroscler Plus 2023;54:1-6. doi: 10.1016/j.athplu.2023.09.001

7.         Barkas F, Ray KK. The global diagnostic network: what can we learn from half a billion lipid measurements between 2018 and 2020? Eur Heart J 2023;44:2319-2321. doi: 10.1093/eurheartj/ehad308

8.         Barkas F, Bathrellou E, Nomikos T, Panagiotakos D, Liberopoulos E, Kontogianni MD. Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention. Nutrients 2023;15. doi: 10.3390/nu15132845

9.         Barkas F, Ntekouan SF, Liberopoulos E, Filippatos T, Milionis H. Sodium-Glucose Cotransporter-2 Inhibitors and Protection Against stroke in Patients with type 2 Diabetes and Impaired Renal Function: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis 2021;30:105708. doi: 10.1016/j.jstrokecerebrovasdis.2021.105708

10.       Barkas F, Filippas-Ntekouan S, Kosmidou M, Liberopoulos E, Liontos A, Milionis H. Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis. Rheumatology (Oxford) 2021;60:5527-5537. doi: 10.1093/rheumatology/keab447

11.       Barkas F, Nomikos T, Liberopoulos E, Panagiotakos D. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis. Nutrients 2020;12. doi: 10.3390/nu12082436

12.       Barkas F, Liamis G, Elisaf M, Anastasiou G, Liberopoulos E. Metabolically healthy obesity and risk of incident type 2 diabetes in 1077 statin-treated individuals: A six-year retrospective study. Eur J Prev Cardiol 2020;27:2341-2344. doi: 10.1177/2047487319899191

13.       Barkas F, Elisaf M, Liberopoulos E, Liamis G, Ntzani EE, Rizos EC. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity. J Cardiol 2019;74:290-295. doi: 10.1016/j.jjcc.2019.02.009

14.       Milionis H, Barkas F, Ntaios G, Papavasileiou V, Vemmos K, Michel P, Elisaf M. Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: Effect on stroke risk. Eur J Intern Med 2016;34:54-57. doi: 10.1016/j.ejim.2016.06.023

15.       Barkas F, Elisaf M, Liberopoulos E, Liontos A, Rizos EC. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome. Atherosclerosis 2016;247:58-63. doi: 10.1016/j.atherosclerosis.2016.02.001

16.       Barkas F, Elisaf M, Liberopoulos E, Klouras E, Liamis G, Rizos EC. Statin therapy with or without ezetimibe and the progression to diabetes. J Clin Lipidol 2016;10:306-313. doi: 10.1016/j.jacl.2015.11.015

17.       Barkas F, Elisaf M, Milionis H. Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis. Atherosclerosis 2015;243:60-64. doi: 10.1016/j.atherosclerosis.2015.08.038